↓ Skip to main content

Dove Medical Press

Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
40 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
13 Mendeley
Title
Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives
Published in
Therapeutics and Clinical Risk Management, July 2022
DOI 10.2147/tcrm.s325916
Pubmed ID
Authors

Aisha Shaikh, Justina Ray, Kirk N Campbell

X Demographics

X Demographics

The data shown below were collected from the profiles of 40 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 23%
Professor > Associate Professor 1 8%
Student > Postgraduate 1 8%
Unknown 8 62%
Readers by discipline Count As %
Medicine and Dentistry 4 31%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Unknown 8 62%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2022.
All research outputs
#1,552,780
of 25,584,565 outputs
Outputs from Therapeutics and Clinical Risk Management
#60
of 1,308 outputs
Outputs of similar age
#34,658
of 440,837 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 17 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,837 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.